AnGes MG licenses in cervical cancer vaccine Genorac BL from BioLeaders, South Korea

The human papillomavirus (HPV) vaccine was invented by BioLeaders and will be clinically developed in Japan by Tokyo Medical School

AnGes MG press release, April 3, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny